Jaguar Health (JAGX) News Today $5.51 -0.10 (-1.78%) Closing price 04/17/2025 04:00 PM EasternExtended Trading$5.45 -0.06 (-1.07%) As of 04/17/2025 04:56 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisChartCompetitorsEarningsHeadlinesOwnershipSEC FilingsShort InterestTrendsBuy This Stock All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 Time Period Jaguar Health’s Napo reports preliminary results from IIT trial of crofelemerApril 17 at 6:53 PM | markets.businessinsider.comJaguar Health to present results from OnTarget study in breast cancer patientsApril 16, 2025 | markets.businessinsider.comJaguar Health files to sell 1.29M shares of common stock for holdersApril 16, 2025 | markets.businessinsider.comJaguar Animal Health trading resumesApril 11, 2025 | markets.businessinsider.comJaguar Animal Health trading halted, volatility trading pauseApril 11, 2025 | markets.businessinsider.comJaguar Health outlines key Q2 2025 catalysts for crofelemer programsApril 1, 2025 | msn.comJaguar Health, Inc. (NASDAQ:JAGX) Q4 2024 Earnings Call TranscriptApril 1, 2025 | msn.comJaguar Health reports FY24 EPS ($5.23) vs. ($1.79) last yearApril 1, 2025 | markets.businessinsider.comJaguar Health, Inc. (JAGX) Q4 2024 Earnings Call TranscriptMarch 31, 2025 | seekingalpha.comJaguar Health announces results of veterinary oncologists on Canalevia-CA1March 29, 2025 | markets.businessinsider.comStockNews.com Begins Coverage on Jaguar Health (NASDAQ:JAGX)StockNews.com assumed coverage on Jaguar Health in a research report on Friday. They set a "sell" rating on the stock.March 28, 2025 | marketbeat.comShort Interest in Jaguar Health, Inc. (NASDAQ:JAGX) Declines By 96.3%Jaguar Health, Inc. (NASDAQ:JAGX - Get Free Report) was the recipient of a significant decline in short interest in March. As of March 15th, there was short interest totalling 35,700 shares, a decline of 96.3% from the February 28th total of 953,100 shares. Based on an average trading volume of 22,800 shares, the days-to-cover ratio is currently 1.6 days. Currently, 0.3% of the company's stock are short sold.March 28, 2025 | marketbeat.comJaguar Health’s Napo granted FDA Type C Meeting to discuss OnTarget studyMarch 27, 2025 | markets.businessinsider.comJaguar Health, Inc.: Jaguar Health Meeting with FDA Regarding Results of Phase 3 OnTarget StudyMarch 27, 2025 | finanznachrichten.deJaguar Health granted Napo a Type C Meeting by FDAMarch 27, 2025 | markets.businessinsider.comJaguar Animal Health trading halted, news pendingMarch 22, 2025 | markets.businessinsider.comJaguar Health, Inc.: Jaguar Health Adopts Limited Duration Stockholder Rights Plan to Ensure Stockholders Can Realize Long-Term ValueFebruary 27, 2025 | finanznachrichten.deJaguar Health adopts limited duration stockholder rights planFebruary 27, 2025 | markets.businessinsider.comJaguar Health extends collaboration with Streeterville to develop P-300February 20, 2025 | markets.businessinsider.comJaguar Health receives regulatory clearance in Germany, Italy for crofelemerFebruary 19, 2025 | markets.businessinsider.comJaguar Health extends collaboration with StreetervilleFebruary 18, 2025 | markets.businessinsider.comJaguar Health extends loan maturity, issues stock for royalty interest reductionFebruary 4, 2025 | msn.comJaguar Health announces first SBS-IF patient dosed in IIT trial of crofelemerFebruary 3, 2025 | markets.businessinsider.comJaguar Health announces first patient dosed in IIT evaluating crofelemerJanuary 24, 2025 | markets.businessinsider.comJaguar Health Stock Hits 52-Week Low at $0.81 Amid ChallengesJanuary 24, 2025 | msn.comHattiesburg Zoo’s jaguar experiencing health problemsJanuary 16, 2025 | yahoo.comJaguar Health announces import of coca leaf by Magdalena Biosciences JVDecember 20, 2024 | markets.businessinsider.comU.S. Investigator-Initiated Trial (IIT) to Evaluate Jaguar Health’s Crofelemer for Short Bowel Syndrome with Intestinal Failure (SBS-IF) BeginsDecember 6, 2024 | markets.businessinsider.comJaguar Health seeking partner to develop, commercialize NP300November 23, 2024 | markets.businessinsider.comJaguar Health, Inc.: Jaguar Health Family Company Napo Therapeutics Named "Best Pharmaceuticals Innovator of the Year - Europe"November 20, 2024 | finanznachrichten.deJaguar Health, Inc. (NASDAQ:JAGX) Q3 2024 Earnings Call TranscriptNovember 16, 2024 | msn.comJaguar Health, Inc. (JAGX) Q3 2024 Earnings Call TranscriptNovember 15, 2024 | seekingalpha.comJaguar Health, Inc.: Jaguar Health Reports Third Quarter 2024 Financial ResultsNovember 14, 2024 | finanznachrichten.deJaguar Health Sees Revenue Growth with New Product LaunchesNovember 14, 2024 | markets.businessinsider.comExploring Jaguar Health's Earnings ExpectationsNovember 13, 2024 | benzinga.comFDA Approves Renewal of Canalevia-CA1, Jaguar Health's Drug for Chemotherapy-Induced Diarrhea in DogsNovember 7, 2024 | markets.businessinsider.comJaguar Health, Inc.: Jaguar Health Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635October 12, 2024 | finanznachrichten.deX-Factor Jaguars Defender Returns to PracticeOctober 12, 2024 | msn.comJaguar Health, Inc.: Magdalena Biosciences, a Joint Venture Between Jaguar Health and Filament Health, to Present October 16 at BIO Investor ForumOctober 10, 2024 | finanznachrichten.deJaguar Health Inc (JAGX) Q2 2024 Earnings Call Highlights: Revenue Growth Amidst Financial ...October 9, 2024 | finance.yahoo.comJaguars back in Jacksonville after 'mechanical issue' delays flightSeptember 25, 2024 | sports.yahoo.comJaguars HC Provides Major Injury Update on Evan Engram's Week 3 StatusSeptember 20, 2024 | msn.comRisk to jaguar habitat illuminates additional costs of drug warSeptember 20, 2024 | msn.comNew Innovators with Jane King Interview with Jaguar Health CEO Lisa Conte Spotlights Company’s Near-Term Commercial & Development MilestonesSeptember 4, 2024 | finance.yahoo.comJaguar Health, Inc.: Patent Issued in Jordan Bolsters IP Protection for Jaguar Health in the Treatment of Short Bowel SyndromeAugust 27, 2024 | finanznachrichten.deJaguar Health Second Quarter 2024 Earnings: Misses ExpectationsAugust 16, 2024 | finance.yahoo.comJaguar Health, Inc. (JAGX) Q2 2024 Earnings Call TranscriptAugust 15, 2024 | seekingalpha.comJaguar Health, Inc. (NASDAQ:JAGX) Q2 2024 Earnings Call TranscriptAugust 15, 2024 | msn.comJaguar Health, Inc.: Jaguar Health Reports Second Quarter 2024 Financial ResultsAugust 14, 2024 | finanznachrichten.deWhy Jaguar Health (JAGX) Stock Is Down 15%August 14, 2024 | msn.com Get Jaguar Health News Delivered to You Automatically Sign up to receive the latest news and ratings for JAGX and its competitors with MarketBeat's FREE daily newsletter. Email Address JAGX Media Mentions By Week JAGX Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. JAGX News Sentiment▼-0.290.57▲Average Medical News Sentiment JAGX News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. JAGX Articles This Week▼41▲JAGX Articles Average Week Get Jaguar Health News Delivered to You Automatically Sign up to receive the latest news and ratings for JAGX and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies CLRB News COCP News ME News SPRB News INAB News QNTM News SYBX News AFMD News MEIP News IMNN News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:JAGX) was last updated on 4/20/2025 by MarketBeat.com Staff From Our PartnersThe real reason gold is soaring (and likely to continue)Trump’s Policies Are Fueling a Gold Boom—Here’s Your Chance to Profit Donald Trump’s bold policies are driv...Golden Portfolio | SponsoredTrump to redistribute trillions of dollars Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredThe first casualty of the 2025 trade warThe headlines scream tariffs and export bans — but the real damage is happening in retirement portfolios. Tim ...Investors Alley | SponsoredMy prediction is coming trueWe've developed a surprisingly effective way to see which stocks could double during massive shake-ups, by usi...InvestorPlace | SponsoredMusk’s AI Masterplan – Our #1 AI Stock to Buy NowDid Elon Musk just set the stage for the next AI stock explosion? One 30-year Wall Street veteran thinks so...Behind the Markets | SponsoredRead before the next tariff announcementLarry Benedict, the acclaimed "Market Wizard," is calling an emergency briefing now... The same Larry who –...Brownstone Research | SponsoredWhy Elon put $51 million into thisWhy Elon Musk Just Invested $51 Million Into Brand New “Miracle Metal” Developed by MIT ScientistsTrue Market Insiders | SponsoredCrypto’s crashing…but we’re still profitingMost traders are panicking right now. Bitcoin’s dropping. Altcoins are bleeding. The stock market’s a mess....Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Jaguar Health, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Jaguar Health With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.